A pharmacist-led follow-up program for patients with established coronary heart disease in North Norway: a randomized controlled trial
| Autor: | Frode Skjold, Beate Hennie Garcia, June Utnes Høgli, Lars Småbrekke, Trude Giverhaug |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Pharmacist Pharmaceutical Science Coronary Disease Pharmacy Pharmacists law.invention Medication Reconciliation Randomized controlled trial law Intervention (counseling) mesh:Coronary Disease Medicine mesh:Pharmacists Risk factor Medical prescription Original Research Randomized Controlled Trials as Topic business.industry Norway mesh:Medication Reconciliation Guideline mesh:Randomized Controlled Trials as Topic Clinical pharmacy mesh:Pharmaceutical Services Pharmaceutical Services Physical therapy business Patient education mesh:Norway |
| Zdroj: | Pharmacy Practice (Granada) v.13 n.2 2015 SciELO España. Revistas Científicas Españolas de Ciencias de la Salud instname Pharmacy Practice |
| Popis: | Objectives: The aim of the study was twofold; 1) to develop a clinical pharmacist-led 12 month lasting follow-up program for patients with established coronary heart disease (CHD) discharged from the University Hospital of North Norway, and 2) to explore the impact of the program with regards to adherence to a medication assessment tool for secondary prevention of CHD and change in biomedical risk factors. Methods: A total of 102 patients aged 18-82 years were enrolled in a non-blinded randomized controlled trial with an intervention group and a control group. The intervention comprised medication reconciliation, medication review and patient education during three meetings; at discharge, after three months and after twelve months. The control group received standard care from their general practitioner. Primary outcomes were adherence to clinical guideline recommendations concerning prescription, therapy goal achievement and lifestyle education defined in the medication assessment tool for secondary prevention of CHD (MAT-CHDSP). Secondary outcomes included changes in the biomedical risk factors cholesterol, blood pressure and blood glucose. Results: Ninety-four patients completed the trial, 48 intervention group patients and 46 controls. Appropriate prescribing was high, but therapy goal achievement was low in both groups. Overall adherence to MAT-CHDSP criteria increased in both groups and was significantly higher in the intervention group at study end, 78.4% vs. 62.0%, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|